Discontinue use if allergic- or anaphylactic-type reactions are suspected. Not to be diluted w/ water for inj. Conditions where hypervolaemia & its consequences or haemodilution represents special risk eg, decompensated cardiac insufficiency, HTN, oesophageal varices, pulmonary oedema, haemorrhagic diathesis, severe anaemia, renal & post-renal anuria. Shock; hypervolaemia. Possibility of transmitting infective agents, unknown or emerging viruses & other pathogens. Patients on controlled Na diet. Regularly monitor haemodynamic performance including arterial BP, pulse rate, central venous & pulmonary artery wedge pressure, urine output, electrolyte, haematocrit/Hb; against circulatory overload & hyperhydration. Ensure adequate hydration & substitution of other blood constituents eg, coagulation factors, electrolytes, platelets & erythrocytes during therapy.